Clinical Trial Update: Study of NGX-4010 for the Treatment of Painful HIV-Associated Neuropathy [Phase 3]

View source ↗

Summary

This clinical trial update notes that a Phase 3 study evaluating NGX-4010 for painful HIV-associated neuropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hiv-associated Neuropathy
• Peripheral Neuropathy

Drugs mentioned

• NGX-4010 (capsaicin patch 8%)

Snippet

Sponsor: NeurogesX | Conditions: HIV Infections, Peripheral Nervous System Diseases | Phase 3 | Status: COMPLETED